Full Text
PMC49 THE ROLE OF PATIENT-REPORTED OUTCOMES (PRO) AS PRIMARY ENDPOINTS IN THE EVALUATION OF MEDICINES APPROVED WITH PRO CLAIMS

Abstract

Authors

M Caron MP Emery

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×